Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of School Diversity on Religious and Ethno-Racial Identity-Based Peer Victimization.

Journal of interpersonal violence·2026
Same author

Pediatric Traumatic Injury in Rural and Urban Areas of Wisconsin.

Pediatric emergency care·2026
Same author

Physical and sexual gender-based violence research embedded within 'care as usual' sexual and reproductive health programming in rural Bolivia: a study protocol.

Global health promotion·2026
Same author

Systematic Preparation of Electronic Health Record Flowsheet Data to Develop Measures of Breastfeeding Intensity and Support During the Postpartum Hospital Stay.

Computers, informatics, nursing : CIN·2026
Same author

Injury across the lifespan: Comparing pediatric and adult injury patterns in the home and the community.

Injury·2026
Same author

Youth Perceptions of the Benefits of a Narrative Sharing Timeline Activity: Findings and Recommendations for Family Nursing Interventions.

Journal of family nursing·2025

Related Experiment Video

Updated: May 17, 2026

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
02:09

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions

Published on: December 20, 2024

Outcomes and complications after splenectomy for hematologic disorders.

Nirav Y Patel1, Abigail M Chilsen, Michelle A Mathiason

  • 1Department of General and Vascular Surgery, Gundersen Lutheran Health System, 1900 South Ave. C03-006B, La Crosse, WI 54601, USA.

American Journal of Surgery
|November 3, 2012
PubMed
Summary

Splenectomy offers a favorable response for immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AHA) when medical therapies fail. This procedure shows low complication rates, making it an effective treatment option.

Related Experiment Videos

Last Updated: May 17, 2026

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
02:09

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions

Published on: December 20, 2024

Area of Science:

  • Hematology
  • Surgical Oncology
  • Immunology

Background:

  • Splenectomy is a second-line treatment for immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AHA) resistant to medical management.
  • Evaluating splenectomy outcomes is crucial for refractory ITP and AHA cases.

Purpose of the Study:

  • To assess the effectiveness and outcomes of splenectomy in patients with ITP and AHA.
  • To determine the response rates and complication profiles associated with splenectomy for these hematologic disorders.

Main Methods:

  • Retrospective review of medical records for patients who underwent splenectomy for ITP or AHA between January 1, 1996, and December 31, 2010.
  • Analysis of patient demographics, initial response, relapse rates, and long-term complications.

Main Results:

  • Out of 60 patients (45 ITP, 15 AHA), initial complete response rates were 91% for ITP and 93% for AHA.
  • Relapse occurred in 17% of ITP and 29% of AHA patients, with an overall sustained complete response rate of 85% (82% ITP, 93% AHA).
  • Thirty-day and long-term complication rates were 10% and 5%, respectively, with no perioperative mortality.

Conclusions:

  • Splenectomy demonstrates favorable response rates and low morbidity in managing ITP and AHA.
  • It serves as an effective adjunct therapy for patients unresponsive to or relapsing after medical treatments.